Movatterモバイル変換


[0]ホーム

URL:


Journal Logo

Email to Colleague

Colleague's E-mail is Invalid

Your Name:
Colleague's Email:
Separate multiple e-mails with a (;).
Message:

Your message has been successfully sent to your colleague.



Some error has occurred while processing your request. Please try after some time.

Export to

HIV INFECTION AND AIDS: Edited by Martin Fisher

Women and HIV

motherhood and more

Anderson, Jane

Author Information

Centre for the Study of Sexual Health and HIV, Homerton University Hospital NHS Foundation Trust, London, UK

Correspondence to Jane Anderson, Centre for the Study of Sexual Health and HIV, Homerton University Hospital NHS Foundation Trust, Homerton Row, London E9 6SR, UK. Tel: +44 208 510 7983; fax: +44 208 510 7979; e-mail:[email protected]

Current Opinion in Infectious Diseases25(1):p 58-65, February 2012. |DOI:10.1097/QCO.0b013e32834ef514

Abstract

Purpose of review 

The number of women living with HIV continues to increase globally. With the availability of efficacious antiretroviral therapy, there is a pressing need to ensure women are treated effectively throughout their life course. This article reviews information on ways that HIV affects women and discusses recent treatment and prevention approaches.

Recent findings 

Because women are at greater risk of heterosexual HIV acquisition than men, new data on biomedical approaches to prevention are of particular relevance. International guidelines for the treatment of pregnant women with HIV now place greater weight on the well being of the mother as well as the prevention of vertical transmission. Although effective HIV treatment for women is associated with better health, longer life, reduced infectiousness and prevention of acquisition of HIV, there is evidence that women experience more adverse effects, discontinue medication more frequently and have more problems with adherence than men.

Summary 

Efficacious anti-HIV drugs exist, but the particular circumstances for women may compromise their effectiveness. Globally, women's access to therapy remains inadequate. More data are needed about the best approaches to HIV therapy for women to include the biological, psychological, social and cultural factors that influence the way women experience HIV infection.

Copyright © 2012 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Log InAccess through Ovid

Source

Current Opinion in Infectious Diseases25(1):58-65, February 2012.
Email to Colleague

Colleague's E-mail is Invalid

Your Name:
Colleague's Email:
Separate multiple e-mails with a (;).
Message:

Your message has been successfully sent to your colleague.



Some error has occurred while processing your request. Please try after some time.


[8]ページ先頭

©2009-2026 Movatter.jp